Research location
Ansbach
Germany
Advertisement
Research activity in Ansbach
GermanyCureCurrent currently publishes aggregate city-level research activity for this location: 17 trials and 18 site observations.
The map is centered on registry-derived city coordinates. Circle size reflects published trial activity.
Below are current trials with one or more ClinicalTrials.gov site observations in this city. Results are paginated 50 per page, with recruiting studies shown first.
Trials with sites in Ansbach
17 linked trials · page 1 of 1A Non-interventional, Prospective Study With BenralizumabNCT06422078 · 2024-07-25 · 1 site observation
RECRUITING
PROVIDENCE - Prospective Non-interventional Study (NIS) to Examine Patient-reported Outcomes and Real-world Clinical Data in Patients With HER2-positive, HER2-low or HER2-ultralow Unresectable or Metastatic Breast Cancer Treated With Trastuzumab DeruxtecanNCT05573893 · 2023-09-12 · 1 site observation
RECRUITING
Non-interventional Study of Risperidone ISM® in Schizophrenia Patients Hospitalised Due to a RelapseNCT05480046 · 2022-10-18 · 1 site observation
COMPLETED
Phase III Study to Assess AZD9833+ CDK4/6 Inhibitor in HR+/HER2-MBC With Detectable ESR1m Before Progression (SERENA-6)NCT04964934 · 2021-06-30 · 1 site observation
ACTIVE_NOT_RECRUITING
Digital Adherence Monitoring of Inhalative Therapy in Real- Life ConditionsNCT04656223 · 2020-12-17 · 1 site observation
COMPLETED
First-line Palbociclib and Endocrine Therapy for Patients With HR+/HER2- Advanced Breast Cancer in the Real-world Setting.NCT04767594 · 2020-10-27 · 1 site observation
ACTIVE_NOT_RECRUITING
Reaching for Evidence-baSed Chemotherapy Use in Endocrine Sensitive Breast CancerNCT03503799 · 2018-07-17 · 1 site observation
ACTIVE_NOT_RECRUITING
Changes in Health and Functional Status in Patients With Chronic Obstructive Pulmonary Disease During Therapy With Spiolto® Respimat® (AERIAL®)NCT03165045 · 2017-05-26 · 1 site observation
COMPLETED
Changes in Physical Functioning in Patients With COPD During Therapy With a Combination Inhalation TherapyNCT02173769 · 2014-06-01 · 1 site observation
COMPLETED
Surgical Trial to Evaluate the Impact of a Lymphoscintigraphy Prior to Sentinel Node Biopsy in Early Breast CancerNCT02481128 · 2014-05-01 · 1 site observation
COMPLETED
Quality of Life in Daxas-treated Patients Older Than 18 Years With Severe COPDNCT01285180 · 2010-08-01 · 1 site observation
COMPLETED
Epidemiological and Scientific Evaluation of EGFR Mutation Status in Patients With Newly Diagnosed Locally Advanced or mNCT00997230 · 2009-09-01 · 1 site observation
COMPLETED
Effectiveness and Safety of Firmagon®NCT00930319 · 2009-06-01 · 2 site observations
COMPLETED
ALTTO (Adjuvant Lapatinib And/Or Trastuzumab Treatment Optimisation) Study; BIG 2-06/N063DNCT00490139 · 2007-05-16 · 1 site observation
COMPLETED
Local Phase 4 Pan-European SMART StudyNCT00463866 · 2007-03-01 · 1 site observation
COMPLETED
Observational Non-interventional Study (Anwendungsbeobachtung) With Telmisartan in High-risk HypertensivesNCT00539487 · 2007-01-01 · 1 site observation
COMPLETED
A Study of Bevacizumab (Avastin) in Women With HER2 Negative Metastatic Breast CancerNCT00333775 · 2006-03-01 · 1 site observation
COMPLETED
Advertisement
Registry-derived research relationships: ClinicalTrials.gov. Raw condition and intervention labels remain distinct from canonical MONDO/RxNorm entities unless separately normalized.